OXFORD, UK, April 11th, 2014
PharmaVentures is pleased to announce that it has been appointed by Novartis as advisors on the future options for its UK Horsham site. These options could include reusing part of the site as a science or business park, thereby creating a legacy with the possibility of creating some highly skilled jobs for the area in the future. PharmaVentures will provide expert advice on the feasibility of doing this, and to help identify potential partners.
See the Novartis press release here.
Dr Fintan Walton, Chief Executive, PharmaVentures, said "The Novartis Horsham site is a perfect location for a high technology park. Novartis has built state of the art facilities, suitable for pharmaceutical / life science or other high technology businesses. With such high quality facilities, we expect interest from both universities and research institutes." Dr Walton added "The site would also be ideal as a business park as Horsham is an attractive location due to its strong international links through Gatwick airport and its proximity to London."